An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+Breast Cancer Cell Lines and Mouse Tumor Xenografts | |
Chen, Qing; Weng, Ziyi; Lu, Yunshu; Jia, Yijun; Ding, Longlong; Bai, Fang; Ge, Meixin; Lin, Qing; Wu, Kejin | |
刊名 | PLOS ONE |
2017 | |
卷号 | 12期号:1 |
ISSN号 | 1932-6203 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3619729 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chen, Qing,Weng, Ziyi,Lu, Yunshu,et al. An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+Breast Cancer Cell Lines and Mouse Tumor Xenografts[J]. PLOS ONE,2017,12(1). |
APA | Chen, Qing.,Weng, Ziyi.,Lu, Yunshu.,Jia, Yijun.,Ding, Longlong.,...&Wu, Kejin.(2017).An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+Breast Cancer Cell Lines and Mouse Tumor Xenografts.PLOS ONE,12(1). |
MLA | Chen, Qing,et al."An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+Breast Cancer Cell Lines and Mouse Tumor Xenografts".PLOS ONE 12.1(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论